FT1050: Preliminary Phase Ib data

Preliminary data from an open-label, U.S. Phase Ib trial in 15 evaluable patients with hematologic malignancies who have undergone non-myeloablative conditioning therapy showed that dual umbilical cord blood

Read the full 281 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE